Tocolytic drugs ineffective for premature birth after 30 weeks

FHS
March 4, 2025
3:12 am

The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health.

Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health

July 20, 2023

What Does the Evidence Say About Immunotherapy Rechallenge in RCC?

Treatment of metastatic renal cell carcinoma (RCC) continues to rapidly evolve, with various combinations of immune checkpoint inhibitors (ICIs) and targeted tyrosine kinase inhibitors improving

June 22, 2023

Medtech group updates EtO standard for first time in 25 years

Dive Brief: The Association for the Advancement of Medical Instrumentation updated its standard on ethylene oxide (EtO) sterilizers used in healthcare facilities, the organization said

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.